The anticoagulant reversal drugs market is expected to reach US$ 2,276.54 million in 2027 from US$ 922.55 million in in 2019; it is estimated to grow at a CAGR of 11.9% from 2019 to 2027. The growth of the anticoagulant reversal drugs market is mainly attributed to rising prevalence of atrial fibrillation (AFib) and stroke. However, the high cost of anticoagulant reversal drugs is restricting the market growth.
Anticoagulant reversal drugs are used in the management of hemorrhagic stroke to decrease ongoing bleeding and allow tissues to recover.
There has been an increase in stroke prevalence in low- and middle-income countries. As per the study ‘Incidence & prevalence of stroke in India: A systematic review’ published in 2017, the cumulative frequency of stroke in India ranged from 105 to 152/100,000 persons per year. Thus, the incidence and prevalence of stroke in India are higher than those of high-income countries.
Additionally, as per the CDC, in 2018, one in every six deaths in the US from cardiovascular disease was due to stroke. It also mentioned that in the US, in every 40 seconds, someone has a stroke, and in every 4 minutes, someone dies of a stroke.
As per the report ‘Burden of Stroke in Europe’ in 2017, there were 1.12 million incident strokes, 9.53 million stroke survivors, 0.46 million deaths, and 7.06 million disability-adjusted life years lost because of stroke in the European Union.
Based on product, the anticoagulant reversal drugs market is segmented into prothrombin complex concentrates, vitamin k, protamine, tranexamic acid, idarucizumab, and AndeXXa. The prothrombin complex concentrates segment held the largest share of the market in 2019; whereas, the AndeXXa segment is estimated to register the highest CAGR in the market during the forecast period. Based on distribution channel, the anticoagulant reversal drugs market is segmented into hospital pharmacies, retail pharmacies, and others. The hospital pharmacies segment held the largest share of the market in 2019, and is estimated to register the highest CAGR in the market during the forecast period.
The World Health Organization, National Health Service, Centers for Disease Control and Prevention, European Pharmacy Network, and European Society of Cardiology, along with company websites, are the major primary and secondary sources cited while preparing this report.
Anticoagulant reversal drugs are used in the management of hemorrhagic stroke to decrease ongoing bleeding and allow tissues to recover.
There has been an increase in stroke prevalence in low- and middle-income countries. As per the study ‘Incidence & prevalence of stroke in India: A systematic review’ published in 2017, the cumulative frequency of stroke in India ranged from 105 to 152/100,000 persons per year. Thus, the incidence and prevalence of stroke in India are higher than those of high-income countries.
Additionally, as per the CDC, in 2018, one in every six deaths in the US from cardiovascular disease was due to stroke. It also mentioned that in the US, in every 40 seconds, someone has a stroke, and in every 4 minutes, someone dies of a stroke.
As per the report ‘Burden of Stroke in Europe’ in 2017, there were 1.12 million incident strokes, 9.53 million stroke survivors, 0.46 million deaths, and 7.06 million disability-adjusted life years lost because of stroke in the European Union.
Based on product, the anticoagulant reversal drugs market is segmented into prothrombin complex concentrates, vitamin k, protamine, tranexamic acid, idarucizumab, and AndeXXa. The prothrombin complex concentrates segment held the largest share of the market in 2019; whereas, the AndeXXa segment is estimated to register the highest CAGR in the market during the forecast period. Based on distribution channel, the anticoagulant reversal drugs market is segmented into hospital pharmacies, retail pharmacies, and others. The hospital pharmacies segment held the largest share of the market in 2019, and is estimated to register the highest CAGR in the market during the forecast period.
The World Health Organization, National Health Service, Centers for Disease Control and Prevention, European Pharmacy Network, and European Society of Cardiology, along with company websites, are the major primary and secondary sources cited while preparing this report.
Table of Contents
1. Introduction1.1 Scope of the Study
1.2 Research Report Guidance
1.3 Market Segmentation
1.3.1 Global Anticoagulant Reversal Drugs Market - By Product
1.3.2 Global Anticoagulant Reversal Drugs Market - By Distribution Channel
1.3.3 Global Anticoagulant Reversal Drugs Market - By Geography
2. Anticoagulant Reversal Drugs Market - Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Anticoagulant Reversal Drugs Market - Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America- PEST Analysis
4.2.2 Europe- PEST Analysis
4.2.3 Asia Pacific- PEST Analysis
4.2.4 Middle East & Africa
4.2.5 South & Central America
4.3 Expert Opinion
5. Anticoagulant Reversal Drugs Market - Key Market Dynamics
5.1 Market Drivers
5.1.1 Rise in Prevalence of Atrial Fibrillation (AFib)
5.1.2 Increase in Prevalence of Stroke
5.2 Market Restraints
5.2.1 High Cost of Anticoagulant Reversal Drugs
5.3 Market Opportunities
5.3.1 Increasing Research Activities on Anticoagulant Reversal Drugs
5.4 Future Trends
5.4.1 Development and Launch of Innovative Products
5.5 Impact Analysis
6. Anticoagulant Reversal Drugs Market - Global Analysis
6.1 Global Anticoagulant Reversal Drugs Market Revenue Forecast And Analysis
6.2 Global Anticoagulant Reversal Drugs Market, By Geography - Forecast And Analysis
6.3 Market Positioning
7. Anticoagulant Reversal Drugs Market- By Product
7.1 Overview
7.2 Anticoagulant Reversal Drugs Market Share, by Product, 2019 and 2027 (%)
7.3 Prothrombin Complex Concentrates
7.3.1 Overview
7.3.2 Prothrombin Complex Concentrates: Anticoagulant Reversal Drugs Market- Revenue and Forecast to 2027 (USD Million)
7.4 Vitamin K
7.4.1 Overview
7.4.2 Vitamin K: Anticoagulant Reversal Drugs Market- Revenue and Forecast to 2027 (USD Million)
7.5 Protamine
7.5.1 Overview
7.5.2 Protamine: Anticoagulant Reversal Drugs Market- Revenue and Forecast to 2027 (USD Million)
7.6 Tranexamic Acid
7.6.1 Overview
7.6.2 Tranexamic Acid: Anticoagulant Reversal Drugs Market- Revenue and Forecast to 2027 (USD Million)
7.7 Idarucizumab
7.7.1 Overview
7.7.2 Idarucizumab: Anticoagulant Reversal Drugs Market- Revenue and Forecast to 2027 (USD Million)
7.8 Andexxa
7.8.1 Overview
7.8.2 Andexxa: Anticoagulant Reversal Drugs Market- Revenue and Forecast to 2027 (USD Million)
8. Anticoagulant Reversal Drugs Market- By Distribution Channel
8.1 Overview
8.2 Anticoagulant Reversal Drugs Market Share, by Distribution Channel, 2019 and 2027 (%)
8.3 Hospital Pharmacies
8.3.1 Overview
8.3.2 Hospital Pharmacies: Anticoagulant Reversal Drugs Market- Revenue and Forecast to 2027 (USD Million)
8.4 Retail Pharmacies
8.4.1 Overview
8.4.2 Retail Pharmacies: Anticoagulant Reversal Drugs Market- Revenue and Forecast to 2027 (USD Million)
8.5 Others
8.5.1 Overview
8.5.2 Others: Anticoagulant Reversal Drugs Market- Revenue and Forecast to 2027 (USD Million)
9. Anticoagulant Reversal Drugs Market - Geographic Analysis
9.1 North America: Anticoagulant Reversal Drugs Market
9.1.1 Overview
9.1.2 North America: Anticoagulant Reversal Drugs Market - Revenue and Forecast to 2027 (USD Million)
9.1.3 North America: Anticoagulant Reversal Drugs Market, by Product, 2018-2027 (USD Million)
9.1.4 North America: Anticoagulant Reversal Drugs Market, by Distribution Channel, 2018-2027 (USD Million)
9.1.5 North America: Anticoagulant Reversal Drugs Market, by Country, 2019 & 2027 (%)
9.1.6 US: Anticoagulant Reversal Drugs Market - Revenue and Forecast to 2027 (USD Million)
9.1.6.1 US: Anticoagulant Reversal Drugs Market - Revenue and Forecast to 2027 (USD Million)
9.1.6.2 US: Anticoagulant Reversal Drugs Market, by Product, 2018-2027 (USD Million)
9.1.6.3 US: Anticoagulant Reversal Drugs Market, by Distribution Channel 2018-2027 (USD Million)
9.1.7 Canada: Anticoagulant Reversal Drugs Market - Revenue and Forecast to 2027 (USD Million)
9.1.7.1 Canada: Anticoagulant Reversal Drugs Market - Revenue and Forecast to 2027 (USD Million)
9.1.7.2 Canada: Anticoagulant Reversal Drugs Market, by Product, 2018-2027 (USD Million)
9.1.7.3 Canada: Anticoagulant Reversal Drugs Market, by Distribution Channel 2018-2027 (USD Million)
9.1.8 Mexico: Anticoagulant Reversal Drugs Market - Revenue and Forecast to 2027 (USD Million)
9.1.8.1 Mexico: Anticoagulant Reversal Drugs Market - Revenue and Forecast to 2027 (USD Million)
9.1.8.2 Mexico: Anticoagulant Reversal Drugs Market, by Product, 2018-2027 (USD Million)
9.1.8.3 Mexico: Anticoagulant Reversal Drugs Market, by Distribution Channel 2018-2027 (USD Million)
9.2 Europe: Anticoagulant Reversal Drugs Market
9.2.1 Overview
9.2.2 Europe: Anticoagulant Reversal Drugs Market - Revenue and Forecast to 2027 (USD Million)
9.2.3 Europe: Anticoagulant Reversal Drugs Market, by Product - Revenue and Forecast to 2027 (USD Million)
9.2.4 Europe: Anticoagulant Reversal Drugs Market, Distribution Channel - Revenue and Forecast to 2027 (USD Million)
9.2.5 Europe: Anticoagulant Reversal Drugs Market, by Country, 2019 & 2027 (%)
9.2.6 Germany: Anticoagulant Reversal Drugs Market - Revenue and Forecast to 2027 (USD Million)
9.2.6.1 Germany: Anticoagulant Reversal Drugs Market - Revenue and Forecast to 2027 (USD Million)
9.2.6.2 Germany: Anticoagulant Reversal Drugs Market, by Product - Revenue and Forecast to 2027 (USD Million)
9.2.6.3 Germany: Anticoagulant Reversal Drugs Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
9.2.7 France: Anticoagulant Reversal Drugs Market - Revenue and Forecast to 2027 (USD Million)
9.2.7.1 France: Anticoagulant Reversal Drugs Market - Revenue and Forecast to 2027 (USD Million)
9.2.7.2 France: Anticoagulant Reversal Drugs Market, by Product- Revenue and Forecast to 2027 (USD Million)
9.2.7.3 France: Anticoagulant Reversal Drugs Market, Distribution Channel - Revenue and Forecast to 2027 (USD Million)
9.2.8 UK: Anticoagulant Reversal Drugs Market - Revenue and Forecast to 2027 (USD Million)
9.2.8.1 UK: Anticoagulant Reversal Drugs Market - Revenue and Forecast to 2027 (USD Million)
9.2.8.2 UK: Anticoagulant Reversal Drugs Market, by Product - Revenue and Forecast to 2027 (USD Million)
9.2.8.3 UK: Anticoagulant Reversal Drugs Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
9.2.9 Italy: Anticoagulant Reversal Drugs Market - Revenue and Forecast to 2027 (USD Million)
9.2.9.1 Italy: Anticoagulant Reversal Drugs Market - Revenue and Forecast to 2027 (USD Million)
9.2.9.2 Italy: Anticoagulant Reversal Drugs Market, by Product - Revenue and Forecast to 2027 (USD Million)
9.2.9.3 Italy: Anticoagulant Reversal Drugs Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
9.2.10 Spain: Anticoagulant Reversal Drugs Market - Revenue and Forecast to 2027 (USD Million)
9.2.10.1 Spain: Anticoagulant Reversal Drugs Market - Revenue and Forecast to 2027 (USD Million)
9.2.10.2 Spain: Anticoagulant Reversal Drugs Market, by Product - Revenue and Forecast to 2027 (USD Million)
9.2.10.3 Spain: Anticoagulant Reversal Drugs Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
9.2.11 Rest of Europe: Anticoagulant Reversal Drugs Market - Revenue and Forecast to 2027 (USD Million)
9.2.11.1 Rest of Europe: Anticoagulant Reversal Drugs Market - Revenue and Forecast to 2027 (USD Million)
9.2.11.2 Rest of Europe: Anticoagulant Reversal Drugs Market, by Product - Revenue and Forecast to 2027 (USD Million)
9.2.11.3 Rest of Europe: Anticoagulant Reversal Drugs Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
9.3 Asia Pacific: Anticoagulant Reversal Drugs Market
9.3.1 Overview
9.3.2 Asia Pacific: Anticoagulant Reversal Drugs Market - Revenue and Forecast to 2027 (USD Million)
9.3.3 Asia Pacific: Anticoagulant Reversal Drugs Market, by Product - Revenue and Forecast to 2027 (USD Million)
9.3.4 Asia Pacific: Anticoagulant Reversal Drugs Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
9.3.5 Asia Pacific: Anticoagulant Reversal Drugs Market, by Country, 2019 & 2027 (%)
9.3.6 China: Anticoagulant Reversal Drugs Market - Revenue and Forecast to 2027 (USD Million)
9.3.6.1 China: Anticoagulant Reversal Drugs Market - Revenue and Forecast to 2027 (USD Million)
9.3.6.2 China: Anticoagulant Reversal Drugs Market, by Product - Revenue and Forecast to 2027 (USD Million)
9.3.6.3 China: Anticoagulant Reversal Drugs Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
9.3.7 Japan: Anticoagulant Reversal Drugs Market - Revenue and Forecast to 2027 (USD Million)
9.3.7.1 Japan: Anticoagulant Reversal Drugs Market - Revenue and Forecast to 2027 (USD Million)
9.3.7.2 Japan: Anticoagulant Reversal Drugs Market, by Product - Revenue and Forecast to 2027 (USD Million)
9.3.7.3 Japan: Anticoagulant Reversal Drugs Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
9.3.8 India: Anticoagulant Reversal Drugs Market - Revenue and Forecast to 2027 (USD Million)
9.3.8.1 India: Anticoagulant Reversal Drugs Market - Revenue and Forecast to 2027 (USD Million)
9.3.8.2 India: Anticoagulant Reversal Drugs Market, by Product - Revenue and Forecast to 2027 (USD Million)
9.3.8.3 India: Anticoagulant Reversal Drugs Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
9.3.9 South Korea: Anticoagulant Reversal Drugs Market - Revenue and Forecast to 2027 (USD Million)
9.3.9.1 South Korea: Anticoagulant Reversal Drugs Market - Revenue and Forecast to 2027 (USD Million)
9.3.9.2 South Korea: Anticoagulant Reversal Drugs Market, by Product - Revenue and Forecast to 2027 (USD Million)
9.3.9.3 South Korea: Anticoagulant Reversal Drugs Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
9.3.10 Australia: Anticoagulant Reversal Drugs Market - Revenue and Forecast to 2027 (USD Million)
9.3.10.1 Australia: Anticoagulant Reversal Drugs Market - Revenue and Forecast to 2027 (USD Million)
9.3.10.2 Australia: Anticoagulant Reversal Drugs Market, by Product - Revenue and Forecast to 2027 (USD Million)
9.3.10.3 Australia: Anticoagulant Reversal Drugs Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
9.3.11 Rest of Asia Pacific: Anticoagulant Reversal Drugs Market - Revenue and Forecast to 2027 (USD Million)
9.3.11.1 Rest of Asia Pacific: Anticoagulant Reversal Drugs Market - Revenue and Forecast to 2027 (USD Million)
9.3.11.2 Rest of Asia Pacific: Anticoagulant Reversal Drugs Market, by Product - Revenue and Forecast to 2027 (USD Million)
9.3.11.3 Rest of Asia Pacific: Anticoagulant Reversal Drugs Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
9.4 Middle East & Africa: Anticoagulant Reversal Drugs Market
9.4.1 Overview
9.4.2 Middle East & Africa: Anticoagulant Reversal Drugs Market - Revenue and Forecast to 2027 (US$ Million)
9.4.3 Middle East & Africa Anticoagulant Reversal Drugs Market, by Product - Revenue and Forecast to 2027 (USD Million)
9.4.4 Middle East & Africa Anticoagulant Reversal Drugs Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
9.4.5 Middle East & Africa: Anticoagulant Reversal Drugs Market, by Country, 2019 & 2027 (%)
9.4.6 Saudi Arabia: Anticoagulant Reversal Drugs Market - Revenue and Forecast to 2027 (USD Million)
9.4.6.1 Saudi Arabia: Anticoagulant Reversal Drugs Market - Revenue and Forecast to 2027 (USD Million)
9.4.6.2 Saudi Arabia Anticoagulant Reversal Drugs Market, by Product - Revenue and Forecast to 2027 (USD Million)
9.4.6.3 Saudi Arabia Anticoagulant Reversal Drugs Market, Type - Revenue and Forecast to 2027 (USD Million)
9.4.7 UAE: Anticoagulant Reversal Drugs Market - Revenue and Forecast to 2027 (USD Million)
9.4.7.1 UAE: Anticoagulant Reversal Drugs Market - Revenue and Forecast to 2027 (USD Million)
9.4.7.2 UAE Anticoagulant Reversal Drugs Market, by Product - Revenue and Forecast to 2027 (USD Million)
9.4.7.3 UAE Anticoagulant Reversal Drugs Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
9.4.8 South Africa: Anticoagulant Reversal Drugs Market - Revenue and Forecast to 2027 (USD Million)
9.4.8.1 South Africa: Anticoagulant Reversal Drugs Market - Revenue and Forecast to 2027 (USD Million)
9.4.8.2 South Africa Anticoagulant Reversal Drugs Market, by Product - Revenue and Forecast to 2027 (USD Million)
9.4.8.3 South Africa Anticoagulant Reversal Drugs Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
9.4.9 Rest of Middle East and Africa: Anticoagulant Reversal Drugs Market - Revenue and Forecast to 2027 (USD Million)
9.4.9.1 Rest of Middle East and Africa: Anticoagulant Reversal Drugs Market - Revenue and Forecast to 2027 (USD Million)
9.4.9.2 Rest of Middle East and Africa Anticoagulant Reversal Drugs Market, by Product - Revenue and Forecast to 2027 (USD Million)
9.4.9.3 Rest of Middle East and Africa Anticoagulant Reversal Drugs Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
9.5 South and Central America: Anticoagulant Reversal Drugs Market
9.5.1 Overview
9.5.2 South and Central America: Anticoagulant Reversal Drugs Market - Revenue and Forecast to 2027 (USD Million)
9.5.3 South and Central America: Anticoagulant Reversal Drugs Market, by Product - Revenue and Forecast to 2027 (USD Million)
9.5.4 South and Central America: Anticoagulant Reversal Drugs Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
9.5.5 South and Central America: Anticoagulant Reversal Drugs Market, by Country, 2019 & 2027 (%)
9.5.6 Brazil: Anticoagulant Reversal Drugs Market - Revenue and Forecast to 2027 (USD Million)
9.5.6.1 Brazil: Anticoagulant Reversal Drugs Market - Revenue and Forecast to 2027 (USD Million)
9.5.6.2 Brazil: Anticoagulant Reversal Drugs Market, by Product - Revenue and Forecast to 2027 (USD Million)
9.5.6.3 Brazil: Anticoagulant Reversal Drugs Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
9.5.7 Argentina: Anticoagulant Reversal Drugs Market - Revenue and Forecast to 2027 (USD Million)
9.5.7.1 Argentina: Anticoagulant Reversal Drugs Market - Revenue and Forecast to 2027 (USD Million)
9.5.7.2 Argentina: Anticoagulant Reversal Drugs Market, by Product - Revenue and Forecast to 2027 (USD Million)
9.5.7.3 Argentina: Anticoagulant Reversal Drugs Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
9.5.8 Rest of South and Central America: Anticoagulant Reversal Drugs Market - Revenue and Forecast to 2027 (USD Million)
9.5.8.1 Rest of South and Central America: Anticoagulant Reversal Drugs Market - Revenue and Forecast to 2027 (USD Million)
9.5.8.2 Rest of South and Central America: Anticoagulant Reversal Drugs Market, by Product - Revenue and Forecast to 2027 (USD Million)
9.5.8.3 Rest of South and Central America: Anticoagulant Reversal Drugs Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
10. Impact of COVID-19 Pandemic on Global Anticoagulant Reversal Drugs Market
10.1 North America: Impact Assessment of COVID-19 Pandemic
10.2 Europe: Impact Assessment of COVID-19 Pandemic
10.3 Asia-Pacific: Impact Assessment of COVID-19 Pandemic
10.4 Middle East and Africa: Impact Assessment of COVID-19 Pandemic
10.5 South and Central America: Impact Assessment of COVID-19 Pandemic
11. Anticoagulant Reversal Drugs Market- Industry Landscape
11.1 Overview
11.2 Growth Strategies Done by the Companies in the Market, (%)
11.3 Organic Developments
11.3.1 Overview
11.3.2 Organic Developments Done By Companies
11.4 Inorganic Developments
11.4.1 Overview
11.4.2 Inorganic Developments Done By Companies
12. Company Profiles
12.1 Boehringer Ingelheim International GmbH
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Pfizer Inc.
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Octapharma AG
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 AMAG PHARMACEUTICALS, INC.
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Fresenius Kabi AG
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Alexion Pharmaceuticals, Inc. (Portola Pharmaceuticals)
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 CSL Limited
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 China Biologic Products, Inc
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 Grifols, S.A.
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 Shanghai RAAS Blood Products Co., Ltd.
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Products and Services
12.10.4 Financial Overview
12.10.5 SWOT Analysis
12.10.6 Key Developments
13. Appendix
13.1 Glossary of Terms
List of Tables
Table 1. North America Anticoagulant Reversal Drugs Market, by Product - Revenue and Forecast to 2027 (USD Million)
Table 2. North America Anticoagulant Reversal Drugs Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
Table 3. US Anticoagulant Reversal Drugs Market, by Product - Revenue and Forecast to 2027 (USD Million)
Table 4. US Anticoagulant Reversal Drugs Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
Table 5. Canada Anticoagulant Reversal Drugs Market, by Product - Revenue and Forecast to 2027 (USD Million)
Table 6. Canada Anticoagulant Reversal Drugs Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
Table 7. Mexico Anticoagulant Reversal Drugs Market, by Product - Revenue and Forecast to 2027 (USD Million)
Table 8. Mexico Anticoagulant Reversal Drugs Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
Table 9. Europe: Anticoagulant Reversal Drugs Market, by Product - Revenue and Forecast to 2027 (USD Million)
Table 10. Europe: Anticoagulant Reversal Drugs Market, Distribution Channel - Revenue and Forecast to 2027 (USD Million)
Table 11. Germany: Anticoagulant Reversal Drugs Market, by Product - Revenue and Forecast to 2027 (USD Million)
Table 12. Germany: Anticoagulant Reversal Drugs Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
Table 13. France: Anticoagulant Reversal Drugs Market, by Product - Revenue and Forecast to 2027 (USD Million)
Table 14. France: Anticoagulant Reversal Drugs Market, Distribution Channel - Revenue and Forecast to 2027 (USD Million)
Table 15. UK: Anticoagulant Reversal Drugs Market, by Product - Revenue and Forecast to 2027 (USD Million)
Table 16. UK: Anticoagulant Reversal Drugs Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
Table 17. Italy: Anticoagulant Reversal Drugs Market, by Product - Revenue and Forecast to 2027 (USD Million)
Table 18. Italy: Anticoagulant Reversal Drugs Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
Table 19. Spain: Anticoagulant Reversal Drugs Market, by Product - Revenue and Forecast to 2027 (USD Million)
Table 20. Spain: Anticoagulant Reversal Drugs Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
Table 21. Rest of Europe: Anticoagulant Reversal Drugs Market, by Product - Revenue and Forecast to 2027 (USD Million)
Table 22. Rest of Europe: Anticoagulant Reversal Drugs Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
Table 23. Asia Pacific: Anticoagulant Reversal Drugs Market, by Product - Revenue and Forecast to 2027 (USD Million)
Table 24. Asia Pacific: Anticoagulant Reversal Drugs Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
Table 25. China: Anticoagulant Reversal Drugs Market, by Product - Revenue and Forecast to 2027 (USD Million)
Table 26. China: Anticoagulant Reversal Drugs Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
Table 27. Japan: Anticoagulant Reversal Drugs Market, by Product - Revenue and Forecast to 2027 (USD Million)
Table 28. Japan: Anticoagulant Reversal Drugs Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
Table 29. India: Anticoagulant Reversal Drugs Market, by Product - Revenue and Forecast to 2027 (USD Million)
Table 30. India: Anticoagulant Reversal Drugs Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
Table 31. South Korea: Anticoagulant Reversal Drugs Market, by Product - Revenue and Forecast to 2027 (USD Million)
Table 32. South Korea: Anticoagulant Reversal Drugs Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
Table 33. Australia: Anticoagulant Reversal Drugs Market, by Product - Revenue and Forecast to 2027 (USD Million)
Table 34. Australia: Anticoagulant Reversal Drugs Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
Table 35. Rest of Asia Pacific: Anticoagulant Reversal Drugs Market, by Product - Revenue and Forecast to 2027 (USD Million)
Table 36. Rest of Asia Pacific: Anticoagulant Reversal Drugs Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
Table 37. Middle East & Africa Anticoagulant Reversal Drugs Market, by Product - Revenue and Forecast to 2027 (USD Million)
Table 38. Middle East & Africa Anticoagulant Reversal Drugs Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
Table 39. Saudi Arabia Anticoagulant Reversal Drugs Market, by Product - Revenue and Forecast to 2027 (USD Million)
Table 40. Saudi Arabia Anticoagulant Reversal Drugs Market, Type - Revenue and Forecast to 2027 (USD Million)
Table 41. UAE Anticoagulant Reversal Drugs Market, by Product - Revenue and Forecast to 2027 (USD Million)
Table 42. UAE Anticoagulant Reversal Drugs Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
Table 43. South Africa Anticoagulant Reversal Drugs Market, by Product - Revenue and Forecast to 2027 (USD Million)
Table 44. South Africa: Anticoagulant Reversal Drugs Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
Table 45. Rest of Middle East and Africa Anticoagulant Reversal Drugs Market, by Product - Revenue and Forecast to 2027 (USD Million)
Table 46. Rest of Middle East and Africa Anticoagulant Reversal Drugs Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
Table 47. South and Central America: Anticoagulant Reversal Drugs Market, by Product - Revenue and Forecast to 2027 (USD Million)
Table 48. South and Central America: Anticoagulant Reversal Drugs Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
Table 49. Brazil: Anticoagulant Reversal Drugs Market, by Product - Revenue and Forecast to 2027 (USD Million)
Table 50. Brazil: Anticoagulant Reversal Drugs Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
Table 51. Argentina: Anticoagulant Reversal Drugs Market, by Product - Revenue and Forecast to 2027 (USD Million)
Table 52. Argentina: Anticoagulant Reversal Drugs Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
Table 53. Rest of South and Central America: Anticoagulant Reversal Drugs Market, by Product - Revenue and Forecast to 2027 (USD Million)
Table 54. Rest of South and Central America: Anticoagulant Reversal Drugs Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
Table 55. Glossary of Terms, Anticoagulant Reversal Drugs MarketList of Figures
Figure 1. Anticoagulant Reversal Drugs Market Segmentation
Figure 2. Anticoagulant Reversal Drugs Market, By Region
Figure 3. Global Anticoagulant Reversal Drugs Market Overview
Figure 4. Prothrombin Complex Concentrates Segment Held Largest Share of Product Segment In Anticoagulant Reversal Drugs Market
Figure 5. Asia-Pacific Region Is Expected to Show Remarkable Growth During the Forecast Period
Figure 6. Global Anticoagulant Reversal Drugs Market, By Geography (USD Million)
Figure 7. Global Anticoagulant Reversal Drugs Market- Leading Country Markets (USD Million)
Figure 8. Global Anticoagulant Reversal Drugs Market, Industry Landscape
Figure 9. North America PEST Analysis
Figure 10. Europe PEST Analysis
Figure 11. Asia Pacific PEST Analysis
Figure 12. Middle East & Africa Analysis
Figure 13. South & Central America PEST Analysis
Figure 14. Expert Opinion
Figure 15. Anticoagulant Reversal Drugs Market Impact Analysis of Drivers and Restraints
Figure 16. Global Anticoagulant Reversal Drugs Market - Revenue Forecast And Analysis - 2019- 2027
Figure 17. Global Anticoagulant Reversal Drugs Market - By Geography Forecast and Analysis - 2019- 2027
Figure 18. Global Anticoagulant Reversal Drugs Market - By Geography Forecast and Analysis - 2019- 2027
Figure 19. Anticoagulant Reversal Drugs Market Share, by Product, 2019 and 2027 (%)
Figure 20. Prothrombin Complex Concentrates: Anticoagulant Reversal Drugs Market- Revenue and Forecast to 2027 (USD Million)
Figure 21. Vitamin K: Anticoagulant Reversal Drugs Market- Revenue and Forecast to 2027 (USD Million)
Figure 22. Protamine: Anticoagulant Reversal Drugs Market- Revenue and Forecast to 2027 (USD Million)
Figure 23. Tranexamic Acid: Anticoagulant Reversal Drugs Market- Revenue and Forecast to 2027 (USD Million)
Figure 24. Idarucizumab: Anticoagulant Reversal Drugs Market- Revenue and Forecast to 2027 (USD Million)
Figure 25. Andexxa: Anticoagulant Reversal Drugs Market- Revenue and Forecast to 2027 (USD Million)
Figure 26. Anticoagulant Reversal Drugs Market Share, by Distribution Channel, 2019 and 2027 (%)
Figure 27. Hospital Pharmacies: Anticoagulant Reversal Drugs Market- Revenue and Forecast to 2027 (USD Million)
Figure 28. Retail Pharmacies: Anticoagulant Reversal Drugs Market- Revenue and Forecast to 2027 (USD Million)
Figure 29. Others: Anticoagulant Reversal Drugs Market- Revenue and Forecast to 2027 (USD Million)
Figure 30. North America: Anticoagulant Reversal Drugs Market, by Key Country - Revenue (2019) (USD Million)
Figure 31. North America Anticoagulant Reversal Drugs Market Revenue and Forecast to 2027 (USD Million)
Figure 32. North America: Anticoagulant Reversal Drugs Market, by Country, 2019 & 2027 (%)
Figure 33. US: Anticoagulant Reversal Drugs Market - Revenue and Forecast to 2027 (USD Million)
Figure 34. Canada: Anticoagulant Reversal Drugs Market - Revenue and Forecast to 2027 (USD Million)
Figure 35. Mexico: Anticoagulant Reversal Drugs Market - Revenue and Forecast to 2027 (USD Million)
Figure 36. Europe: Anticoagulant Reversal Drugs Market, by Key Country - Revenue (2019) (USD Million)
Figure 37. Europe: Anticoagulant Reversal Drugs Market Revenue and Forecast to 2027 (USD Million)
Figure 38. Europe: Anticoagulant Reversal Drugs Market, by Country, 2019 & 2027 (%)
Figure 39. Germany: Anticoagulant Reversal Drugs Market - Revenue and Forecast to 2027 (USD Million)
Figure 40. France: Anticoagulant Reversal Drugs Market - Revenue and Forecast to 2027 (USD Million)
Figure 41. UK: Anticoagulant Reversal Drugs Market - Revenue and Forecast to 2027 (USD Million)
Figure 42. Italy: Anticoagulant Reversal Drugs Market - Revenue and Forecast to 2027 (USD Million)
Figure 43. Spain: Anticoagulant Reversal Drugs Market - Revenue and Forecast to 2027 (USD Million)
Figure 44. Rest of Europe: Anticoagulant Reversal Drugs Market - Revenue and Forecast to 2027 (USD Million)
Figure 45. Asia Pacific: Anticoagulant Reversal Drugs Market, by Key Country - Revenue (2019) (USD Million)
Figure 46. Asia Pacific: Anticoagulant Reversal Drugs Market Revenue and Forecast to 2027 (USD Million)
Figure 47. Asia Pacific: Anticoagulant Reversal Drugs Market, by Country, 2019 & 2027 (%)
Figure 48. China: Anticoagulant Reversal Drugs Market - Revenue and Forecast to 2027 (USD Million)
Figure 49. Japan: Anticoagulant Reversal Drugs Market - Revenue and Forecast to 2027 (USD Million)
Figure 50. India: Anticoagulant Reversal Drugs Market - Revenue and Forecast to 2027 (USD Million)
Figure 51. South Korea: Anticoagulant Reversal Drugs Market - Revenue and Forecast to 2027 (USD Million)
Figure 52. Australia: Anticoagulant Reversal Drugs Market - Revenue and Forecast to 2027 (USD Million)
Figure 53. Rest of Asia Pacific: Anticoagulant Reversal Drugs Market - Revenue and Forecast to 2027 (USD Million)
Figure 54. Middle East & Africa: Anticoagulant Reversal Drugs Market, by Key Country - Revenue (2019) (USD Million)
Figure 55. Middle East & Africa Anticoagulant Reversal Drugs Market Revenue and Forecast to 2027 (USD Million)
Figure 56. Middle East & Africa: Anticoagulant Reversal Drugs Market, by Country, 2019 & 2027 (%)
Figure 57. Saudi Arabia: Anticoagulant Reversal Drugs Market - Revenue and Forecast to 2027 (USD Million)
Figure 58. UAE: Anticoagulant Reversal Drugs Market - Revenue and Forecast to 2027 (USD Million)
Figure 59. South Africa: Anticoagulant Reversal Drugs Market - Revenue and Forecast to 2027 (USD Million)
Figure 60. Rest of Middle East and Africa: Anticoagulant Reversal Drugs Market - Revenue and Forecast to 2027 (USD Million)
Figure 61. South and Central America: Anticoagulant Reversal Drugs Market, by Key Country - Revenue (2019) (USD Million)
Figure 62. South and Central America: Anticoagulant Reversal Drugs Market Revenue and Forecast to 2027 (USD Million)
Figure 63. South and Central America: Anticoagulant Reversal Drugs Market, by Country, 2019 & 2027 (%)
Figure 64. Brazil: Anticoagulant Reversal Drugs Market - Revenue and Forecast to 2027 (USD Million)
Figure 65. Argentina: Anticoagulant Reversal Drugs Market - Revenue and Forecast to 2027 (USD Million)
Figure 66. Rest of South and Central America: Anticoagulant Reversal Drugs Market - Revenue and Forecast to 2027 (USD Million)
Figure 67. Impact of COVID-19 Pandemic in North American Country Markets
Figure 68. Impact of COVID-19 Pandemic in European Country Markets
Figure 69. Impact of COVID-19 Pandemic in Asia Pacific Country Markets
Figure 70. Impact of COVID-19 Pandemic in Middle East and Africa Market
Figure 71. Impact of COVID-19 Pandemic in South and Central America Market
Figure 72. Growth Strategies Done by the Companies in the Market, (%)
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Boehringer Ingelheim International GmbH
- Pfizer Inc.
- Octapharma AG
- AMAG PHARMACEUTICALS, INC.
- Fresenius Kabi AG
- Alexion Pharmaceuticals, Inc. (Portola Pharmaceuticals)
- CSL Limited
- China Biologic Products, Inc
- Grifols, S.A.
- Shanghai RAAS Blood Products Co.
Table Information
| Report Attribute | Details |
|---|---|
| Published | January 2021 |
| Forecast Period | 2019 - 2027 |
| Estimated Market Value ( USD | $ 922.55 Million |
| Forecasted Market Value ( USD | $ 2276.54 Million |
| Compound Annual Growth Rate | 11.9% |
| Regions Covered | Global |
